Parallel Advisors’s BioCardia BCDA Stock Holding History

Parallel Advisors’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3	Closed	–	–	2791
2020 Q4	$0	Buy	+3	New	+$120	﹤0.01%	2568

Other funds holding BCDA

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Parallel Advisors's BCDA Position: Q1 2021 in Review

Parallel Advisors sold out of BioCardia (BCDA) in Q1 2021, closing a stake of 3 shares.

Parallel Advisors first reported a position in BCDA in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 19 funds tracked by Wall St. Rank hold BCDA as of Q1 2021.

Parallel Advisors reported no remaining BioCardia position as of Q1 2021 after selling out during the quarter.
Parallel Advisors sold 3 BioCardia shares in Q1 2021.
Parallel Advisors first reported a position in BioCardia in Q4 2020 and held it in 1 quarter.
Parallel Advisors's BioCardia position peaked at $0 in Q4 2020.
19 funds tracked by Wall St. Rank held BioCardia as of Q1 2021.

Based on Parallel Advisors's 13F filing for Q1 2021, filed 23 Apr 2021.